EMA Withdrawn: Dengvaxia (chimeric yellow fever dengue virus serotype 1 (live, attenuated);chimeric yellow fever dengue virus serotype 2 (live, attenuated);chimeric yellow fever dengue virus serotype 3 (live, attenuated);chimeric yellow fever dengue virus serotype 4 (live, attenuated)) — Sanofi Winthrop Industrie

View source ↗

Summary

The EMA has withdrawn Dengvaxia from use in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Dengvaxia (CYD-TDV)

Snippet

Status: Withdrawn. Therapeutic area: Dengue. MAH: Sanofi Winthrop Industrie. Decision date: 12/12/2024